European journal of preventive cardiology · 2025
Exercise intensity and cardiac disease development in carriers of titin truncating variants.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Savonitto Giulio, Paldino Alessia, Setti Martina, Berra Arianna, Radesich Cinzia, Perotto Maria, Del Mestre Eva, Cittar Marco, Tavcar Irena, Ribichini Flavio Luciano, Barbati Giulia, Gigli Marta, Stolfo Davide, Dal Ferro Matteo, Merlo Marco, Sinagra Gianfranco
Аннотация
AIMS: While the exacerbating effect of physical exercise and its correlation with arrhythmic outcomes have been demonstrated for arrhythmogenic right ventricular cardiomyopathy, the impact of physical exercise on other forms of cardiomyopathies is poorly characterized. This study aimed to investigate the relationship between lifelong exercise intensity and the development of cardiac manifestations in subjects carrying a likely pathogenic (LP) or pathogenic (P) truncating variant of titin (TTNtv).
METHODS AND RESULTS: Truncating variant of titin carriers-patients and family members-were interviewed regarding their exercise habits from birth until diagnosis (type of activity, hours/week, weeks/months, months/years, and number of years of exercise). Those engaging in ≥4 h of vigorous exercise per week [equivalent to ≥1440 metabolic equivalents (METs) × minutes/week] for a minimum of 6 years were classified as athletes. All others were classified as non-athletes. The correlation between vigorous physical activity and the development of left ventricular systolic dysfunction (LVSD), defined as left ventricular ejection fraction below 45% (LVEF < 45%), was explored. Additionally, secondary endpoints included the occurrence of life-threatening ventricular arrhythmias [LTA-i.e. aborted cardiac arrest due to hyperkinetic arrhythmias, documented sustained ventricular tachycardia (SVT), or appropriate implantable cardioverter-defibrillator therapy], non-LTA ventricular arrhythmias [i.e. > 1000 premature ventricular complexes/24 h and/or non-sustained ventricular tachycardia (NSVT)], and the development of atrial fibrillation and/or atrial flutter (AF/AFL) during follow-up. Among the 117 subjects (73% male, median age 45-interquartile range 35-57 years), 38 (32%) were athletes. Vigorous exercise was not associated with the development of LVEF < 45% (adjusted odds ratio 0.663, 95% confidence interval 0.261-1.685, P 0.388), nor with the occurrence of LTA (P = 0.607), non-LTA (P = 0.648), and supraventricular arrhythmias (P = 0.701). Comparable results were obtained when considering the total amount of METs × hours/life burned by subjects as a continuous variable.
CONCLUSION: In carriers of TTNtv, vigorous physical activity was not associated with LVSD and LTA development.
METHODS AND RESULTS: Truncating variant of titin carriers-patients and family members-were interviewed regarding their exercise habits from birth until diagnosis (type of activity, hours/week, weeks/months, months/years, and number of years of exercise). Those engaging in ≥4 h of vigorous exercise per week [equivalent to ≥1440 metabolic equivalents (METs) × minutes/week] for a minimum of 6 years were classified as athletes. All others were classified as non-athletes. The correlation between vigorous physical activity and the development of left ventricular systolic dysfunction (LVSD), defined as left ventricular ejection fraction below 45% (LVEF < 45%), was explored. Additionally, secondary endpoints included the occurrence of life-threatening ventricular arrhythmias [LTA-i.e. aborted cardiac arrest due to hyperkinetic arrhythmias, documented sustained ventricular tachycardia (SVT), or appropriate implantable cardioverter-defibrillator therapy], non-LTA ventricular arrhythmias [i.e. > 1000 premature ventricular complexes/24 h and/or non-sustained ventricular tachycardia (NSVT)], and the development of atrial fibrillation and/or atrial flutter (AF/AFL) during follow-up. Among the 117 subjects (73% male, median age 45-interquartile range 35-57 years), 38 (32%) were athletes. Vigorous exercise was not associated with the development of LVEF < 45% (adjusted odds ratio 0.663, 95% confidence interval 0.261-1.685, P 0.388), nor with the occurrence of LTA (P = 0.607), non-LTA (P = 0.648), and supraventricular arrhythmias (P = 0.701). Comparable results were obtained when considering the total amount of METs × hours/life burned by subjects as a continuous variable.
CONCLUSION: In carriers of TTNtv, vigorous physical activity was not associated with LVSD and LTA development.